Institution
Tisch Cancer Institute
Also known as: Mount Sinai Cancer Institute · Mount Sinai Tisch Cancer Institute · Tisch Cancer Center · Tisch Cancer Institute at Mount Sinai
- 7running trials
- 3closed trials
- 7,261publications (OpenAlex)
Running trials
Recruiting
Recruiting
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Recruiting
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
Recruiting
Recruiting
Active, not recruiting
First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma3 recruiting
- Cervical cancer2 recruiting
- Lung cancer2 recruiting
- Pancreatic cancer2 recruiting
- Bladder cancer1 recruiting
- Brain metastases1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Terminated
Completed
Completed
Registry name variants (8)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Tisch Cancer Institute at Mount Sinai
New York, New York 10029
2 trials
NCT07116616A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
Contact: Moderna WeCare Team
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
New York, New York 10029
2 trials
NCT07227168A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Contact: Jordan Cuevas
Contact: Principal Investigator
Mount Sinai School of Medicine - Tisch Cancer Institute
New York, New York 10029
1 trial
Mount Sinai - The Tisch Cancer Institute /ID# 272470
New York, New York 10029
1 trial
Mount Sinai Tisch Cancer Institute
New York, New York 10029
1 trial
The Tisch Cancer Institute/Mount Sinai
New York, New York 10029
1 trial
Contact: Shambavi Richard, MD
Tisch Cancer Institute, Icahn School of Medicine
New York, New York 10029
1 trial
Tisch Cancer Institute (TCI), Icahn School of Medicine
New York, New York 10029-5674
1 trial
Contact: Thomas Marron, MD, PhD (principal investigator)
Conditions
Diseases this institution publishes on or runs trials for.
- Bladder cancer56 works · 2 trials
- Myeloproliferative neoplasms41 works · 0 trials
- Multiple myeloma39 works · 3 trials
- Mesothelioma8 works · 0 trials
Institution data: ROR 0317dzj93 (CC0-1.0)Updated 15 Nov 2026